Implementation Status of Liver Function Tests for Monitoring Benzbromarone-Induced Hepatotoxicity: An Epidemiological Survey Using the Japanese Claims Database-Reference-Cited by-同舟云学术

Implementation Status of Liver Function Tests for Monitoring Benzbromarone-Induced Hepatotoxicity: An Epidemiological Survey Using the Japanese Claims Database

Published:2021-10-01 Issue:10 Volume:44 Page:1499-1505
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Imai Shungo¹,Nasuhara Yasuyuki²,Momo Kenji³,Oki Hiromitsu⁴,Kashiwagi Hitoshi¹,Sato Yuki¹,Miyai Takayuki⁵,Sugawara Mitsuru¹,Takekuma Yoh⁴

Affiliation:

1. Faculty of Pharmaceutical Sciences, Hokkaido University

2. Division of Hospital Safety Management, Hokkaido University Hospital

3. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University

4. Department of Pharmacy, Hokkaido University Hospital

5. Graduate School of Life Science, Hokkaido University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/10/44_b21-00393/_pdf

Reference27 articles.

1. 1) Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, García-Erauskin G, Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann. Rheum. Dis., 57, 545–549 (1998).

2. 2) Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature, 417, 447–452 (2002).

3. 3) Masbernard A, Giudicelli CP. Ten years’ experience with benzbromarone in the management of gout and hyperuricaemia. S. Afr. Med. J., 59, 701–706 (1981).

4. 4) Stamp LK, Haslett J, Frampton C, White D, Gardner D, Stebbings S, Taylor G, Grainger R, Kumar R, Kumar S, Kain T, Porter D, Corkill M, Cathro A, Metcalfe S, Wyeth J, Dalbeth N. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. Intern. Med. J., 46, 1075–1080 (2016).

5. 5) Li S, Yang H, Guo Y, Wei F, Yang X, Li D, Li M, Xu W, Li W, Sun L, Gao Y, Wang Y. Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis. Sci. Rep., 6, 33082 (2016).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters;Phytomedicine;2023-09

2. Identifying the intervention mechanisms of polydatin in hyperuricemia model rats by using UHPLC-Q-Exactive Orbitrap mass spectroscopy metabonomic approach;Frontiers in Nutrition;2023-04-28

3. Lactobacillus acidophilus Fermented Dandelion Improves Hyperuricemia and Regulates Gut Microbiota;Fermentation;2023-04-03

4. A Case of Recent Liver Injury Induced by Benzbromarone;Reports;2022-03-08